A Study of LAD191 in Adults With Hidradenitis Suppurativa

NCT07151937 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Hidradenitis Suppurativa

Interventions

DRUG: LAD191
OTHER: Placebo
DRUG: Adalimumab

Sponsor

Almirall, S.A.